Sponsors (2)
The bill shifts more federal purchasing toward U.S. biobased products and improves procurement transparency and tools to grow domestic biomanufacturing, but it raises the risk of higher costs, narrower supplier options, added administrative work, and potential procurement gaps when suitable biobased products are not available.
Small biobased suppliers, farmers, and rural manufacturers will see increased and prioritized federal demand for U.S.-produced biobased products, boosting market opportunities and supporting domestic feedstock and manufacturing markets.
Policymakers, businesses, and agricultural stakeholders will get improved reporting on estimated economic value and geographic distribution of biomanufacturing, making it easier to target investments and grow regional biobased industries.
Federal contracting staff, agencies, and the public will benefit from greater transparency, verification, and updated training/catalogs (within two years), which should speed implementation and make it easier to identify and purchase eligible biobased products.
Taxpayers and state governments may face higher procurement spending if biobased products cost more than conventional alternatives, increasing overall government purchasing costs.
Procuring agencies and some suppliers could experience narrower supplier pools and higher prices due to stricter domestic-preference/Buy American requirements, raising the risk of supply disruptions or reduced competition.
Federal and state agencies will incur added administrative burdens and costs from new reporting, verification, training, and compliance deadlines required to implement the program.
Based on analysis of 2 sections of legislative text.
Strengthens the federal biobased markets program by raising procurement requirements, tightening oversight and reporting, setting deadlines for training/catalog updates, and prioritizing U.S.-made biobased products.
Official title: Amend the Farm Security and Rural Investment Act of 2002 to enhance the recognition, procurement, and domestic production of biobased products, and for other purposes.
Introduced September 3, 2025 by Todd Young · Last progress September 3, 2025
Amends the federal biobased markets program to strengthen procurement requirements, oversight, reporting, and support for U.S.-produced biobased products. It requires agencies to increase biobased-only contract volumes annually (with limited exceptions for price or Buy American conflicts), tightens reporting and verification by OFPP, sets deadlines for training and catalog updates, revises metrics to show economic and geographic impacts, and directs a GAO review within two years to assess compliance and recommend improvements.